Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661529 · ClinicalTrials.gov registry record · NA
Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts
A NA study of Bidirectional Cardiovascular Shunt, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02661529 is a NA study of Bidirectional Cardiovascular Shunt that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02661529, a NA study of Bidirectional Cardiovascular Shunt, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to answer whether the use of a mixture of blood and saline alone (limited air) provides the same degree of right-heart contrast enhancement as compared to the standard agitated saline (with air), during two types of echocardiograms.
Conditions Studied
Interventions
- PROCEDURE Transesophageal Echocardiogram (TEE)
- PROCEDURE Transthoracic Echocardiogram (TTE)
- OTHER Saline/Air Mixture
- OTHER Saline/Blood Mixture
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02661529
The ClinicalTrials.gov registry entry for NCT02661529 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bidirectional Cardiovascular Shunt appearing as the primary indexed condition, and to 4 interventions - of which Transesophageal Echocardiogram (TEE) is the first listed.
NCT02661529 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02661529 about?
NCT02661529 is a clinical study titled "Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts". The study aims to answer whether the use of a mixture of blood and saline alone (limited air) provides the same degree of right-heart contrast enhancement as compared to the standard agitated saline (with air), during two types of echocardiograms.
What is the current status of trial NCT02661529?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-01. Estimated completion is 2016-07.
What conditions does trial NCT02661529 study?
This clinical trial studies the following conditions: Bidirectional Cardiovascular Shunt.
What interventions are being tested in trial NCT02661529?
The interventions under investigation include: Transesophageal Echocardiogram (TEE) (PROCEDURE), Transthoracic Echocardiogram (TTE) (PROCEDURE), Saline/Air Mixture (OTHER), Saline/Blood Mixture (OTHER).
Who is sponsoring clinical trial NCT02661529?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02661529 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.